Match Document Document Title
7357916 Method for creating a uniform vascular wound in zebrafish or zebrafish larva  
Disclosed are improved methods for creating a uniform vascular wound in a zebrafish larva or zebrafish. The methods illustratively include subjecting a zebrafish larva to laser irradiation in an...
7351542 Methods of modulating tubulin deacetylase activity  
The present invention provides methods for identifying agents that modulate a level or an activity of tubulin deacetylase polypeptide, as well as agents identified by the methods. The invention...
7353153 Method and system for modeling bone structure  
The present invention discloses a structural and mechanical model and modeling methods for human bone based on bone's hierarchical structure and on its hierarchical mechanical behavior. The model...
7344703 Mycobacterial sulfation pathway proteins and methods of use thereof  
Novel mycobacterial sulfation pathway proteins and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are provided. The subject polypeptide and nucleic acid...
7344701 Xanthene dyes  
The invention provides a novel class of xanthene dyes, some of which are functionalized to allow their coupling to conjugation partners of interest, e.g. biomolecules, drugs, toxins and the like....
7341710 Method of identifying molecules that home to a selected organ in vivo  
The present invention provides methods for in vivo panning of a library to identify molecules that specifically home to a selected organ.
7335369 Fusion proteins of mycobacterium tuberculosis antigens and their uses  
The present invention relates to fusion proteins containing at least two Mycobacterium tuberculosis antigens. In particular, it relates to bi-fusion proteins which contain two individual M....
7335480 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same  
The disclosed technology provides an enriched antibody population, highly specific for an antigen of a surface polysaccharide, from a mycobacterium. In a related embodiment, the antibody is...
7335640 Administration of hypocretin-1 for treatment of narcolepsy  
The invention provides compositions and methods for treatment of sleep disorders. Such methods entail administering to the patient a therapeutically effective dosage regime of an agonist of a...
7335632 Beta-secretase inhibitors and methods of use thereof  
The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease.
7323175 Immunogenicity of glucan binding protein  
Immunogenic compositions and subunit vaccines for dental caries are described which comprise peptide subunits of glucan binding protein-B and peptide subunits of glucan binding protein-B in...
7320785 Compositions and methods for modulation of DARPP-32 phosphorylation  
The present invention provides methods and compositions for modulating the phosphorylation of DARPP-32 in a serotonergic receptor intracellular signaling pathway. The invention provides methods and...
7318917 Rapid assays for neurotransmitter transporters  
The invention describes the finding that 4-(4-dimethylaminostyrl)-N-methylpyridinium or ASP + is a fluorescent substrate that is transported by several neurotransmitter transporters. Provided are...
7314724 Therapeutic applications of laminin and laminin-derived protein fragments  
Laminin and specific laminin-derived protein fragments are disclosed as potent inhibitors of Alzheimer's disease type amyloidoses. A specific region is identified within laminin which interacts...
7303739 Prodrugs for liver specific drug delivery  
The present invention is directed towards novel cyclic phosph(oramid)ate prodrugs of alcohol-, amine-, and thiol-containing drugs, their preparation, their synthetic intermediates, and their uses....
7303740 Methods for the diagnosis and treatment of breast cancer  
The present invention provides a method for diagnosing breast cancer in a subject. The present invention also provides a method for treating breast cancer in a subject. Finally, the present...
7300763 Method of testing myelotoxicity with the use of flow cytometer  
The objects of the present invention are to solve low test efficiency and low accuracy which are problems encountered in the conventional methods for testing myelotoxicity of a drug by observing...
7297339 Rhodococcus equi mutants and vaccines comprising same  
Mutant strains of Rhodococcus equi are disclosed, and vaccines comprising same.
7294738 Phosphorous containing steroid mimics  
The present invention discloses novel steroid mimics wherein a tri- or tetravalent phosphorous atom is isosterically substituted at any one of the seventeen positions occupied by the carbon atom in...
7291710 Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage  
Methods for detecting a cell damage relate to the discovery that proteases are selectively activated in subjects suffering from nervous system damage compared to samples from healthy subjects....
7288244 Determining vulnerable plaque in blood vessels  
The invention is based on the realisation that inflamed plaques in blood vessel walls, which are potentially vulnerable to rupture, can be detected at elevated temperatures which are lower than...
7288261 Mid-life vaccine and methods for boosting anti-mycobacterial immunity  
Vaccine compositions for boosting immunity to mycobacteria when administered in mid-life in a subject who has been vaccinated neonatally or in early childhood with BCG and in whom protective...
7283940 Multidirectional morphology and mechanics of osteonic lamellae  
The present invention discloses a structural and mechanical model and modeling methods for human bone based on bone's hierarchical structure and on its hierarchical mechanical behavior. The model...
7279170 32-kDa protein derived from Mycobacterium tuberculosis and related peptides  
The invention relates to recombinant polypeptides and peptides and particularly to the polypeptide containing in its polypeptidic chain the following amino acid sequence: the one extending from the...
7276581 Mutated Src oncogene composition and methods  
The present invention provides a mutant oligonucleotide composition encoding a cellular c-Src tyrosine kinase oncogene. Methods for isolating, expressing and characterizing recombinant Src mutant...
7276350 Method for diagnosing infectious diseases  
A method for diagnosing the presence in an animal of an infection due to a microorganism in which a test sample obtained from the animal is exposed to a population of the microorganism and the...
7270800 Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition  
This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising...
7270801 Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof  
The present invention relates to novel fluorescent dyes, novel fluorogenic and fluorescent reporter molecules and new enzyme assay processes that can be used to detect the activity of caspases and...
7270962 Method of identifying modulators of nogo-functions  
A method of identifying a modulator Nogo function, the method comprising: (i) providing (a) a BACE polypeptide; (b) a Nogo polypeptide; (c) a test agent under conditions that...
7264815 Process for producing a recombinant protein in a mycobacterium host plasmid pJAM2  
This invention relates to a novel mycobacterial protein named DES, which appears to share significant amino acid sequence homology with soluble stearoyl-ACP desaturases. The results of allelic...
7252824 Anti-neovasculature preparations for cancer  
Disclosed herein are immunogenic compositions, methods of designing immunogenic compositions, methods of treatment using immunogenic compositions, methods of evaluating cell-mediated immunity...
7247302 Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis  
The present invention provides a method for inhibiting immunoglobulin-induced toxicity resulting from immunotherapy in a subject comprising administering an immunoglobulin or Ig fusion protein...
7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia  
Disclosed is a method of manipulating the rate of upper gastrointestinal transit of a substance in a mammal. Also disclosed are methods of manipulating satiety and post-prandial visceral blood...
7238359 Antigen ORF Rv2430c and a method thereof  
The present invention relates to a PPE family antigenic protein Rv2430c of SEQ ID No. 1; a set of three high antigenic index peptides of SEQ ID Nos. 2 to 4; an antigenic ORF Rv2430c of SEQ ID No. 5...
7235375 Organic anion transport proteins  
The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with...
7229605 Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles  
Methods for determining the effect of a Clostridial neurotoxin on muscle are disclosed. In particular, methods for determining a potency and/or diffusion of a neurotoxin based on a nuclear index...
7229773 Screening method for apoptosis-suppressing or-promoting substance  
To provide a screening method for an apoptosis-suppressing substance or an apoptosis-promoting substance, the application of which substances to pharmaceuticals or diagnostic drugs are expected,...
7220890 Chimeric mouse model for endometriosis  
A non-human animal model for endometriosis is provided as well as methods of making and using the animal.
7217411 CeSERT genes, proteins, and modulatory compounds  
The invention features substantially pure nucleic acid sequences encoding wild-type or mutant serotonin reuptake transporter (SERT) polypeptides, as well as the polypeptides themselves. The...
7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof  
The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polynucleotides in applications including immunization, generation of packaging cell lines, and...
7196115 Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor  
The present invention relates to the bioactivity of taxanes isolated from the leaves of Himalayan Yew tree Taxus wallichiana against human cancer cell lines grown in-vitro and subsequent...
7186556 Modulating transcription of genes in vascular cells  
A method of modulating the transcription of one or more genes in a vascular or cardiac cell, wherein the method comprises a step of contacting the cell with a composition comprising one or more...
7179447 Type I interferon-producing cells and uses thereof  
The present invention provides compositions for the treatment, inhibition or prevention of diseases or disorders, including cancer, immune diseases or disorders, and infectious diseases, comprising...
7175830 Imaging of drug accumulation as a guide to antitumor therapy  
The use of radio-labeled antitumor drugs in the treatment of solid tumors by the method of administering a radio-labeled anticancer drug to a patient and imaging at least a part of the patient...
7176181 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth  
The present invention provides compositions that enhance or inhibit the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors,...
7172750 Compositions and methods for the treatment and diagnosis of immune disorders  
The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders. For example, genes which are...
7169564 FKBP51/52 and CyP40-mediated mammalian hair growth  
The present invention relates to drug screening assays designed to identify non-immunosuppressive agents that modulate hair growth and the use of such agents for modulation of hair growth.
7166270 Methods of screening compounds useful for prevention of infection or pathogenicity  
Screening procedures are disclosed for identifying compounds useful for inhibiting infection or pathogenicity. Methods are also disclosed for identifying pathogenic virulence factors.
7163682 Glucan binding protein and glucosyltransferase immunogens  
Immunogenic compositions and subunit vaccines for dental caries are described which comprise peptide subunits of glucan binding protein-B and peptide subunits of glucan binding protein-B in...
7160548 Mycobacterium strains with modified erp gene and vaccine composition containing same  
Mycobacterium strains in which the erp gene is modified, and vaccine compositions comprising such Mycobacterium strains are provided. The modification of the erp gene may decrease the virulence...